Cambrex Corporation News Headlines

CBM 
$33.97
*  
0.02
0.06%
Get CBM Alerts
*Delayed - data as of Mar. 4, 2015  -  Find a broker to begin trading CBM now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Oncolytics' Reolysin Gets Orphan Drug Status Yet Again - Analyst Blog
3/4/2015 2:38:00 PM - Zacks.com


Nasdaq Breaks 5000: Is A New High On The Horizon?
3/4/2015 9:28:00 AM - Seeking Alpha


Is Illumina (ILMN) Worth Adding to Your Portfolio Now? - Analyst Blog
3/3/2015 5:04:00 PM - Zacks.com


Halozyme Q4 Loss Narrower-than-Expected, Revenues Up - Analyst Blog
3/3/2015 10:33:00 AM - Zacks.com


Biogen/Sobi Report Postive Phase III Data on Alprolix - Analyst Blog
3/2/2015 2:10:00 PM - Zacks.com


Amgen's Kyprolis Under EU Review - Analyst Blog
2/28/2015 7:36:00 PM - Zacks.com


Actavis' Infectious Disease Product, Avycaz, Gets FDA Nod - Analyst Blog
2/26/2015 11:50:00 AM - Zacks.com


Medivation Beats on Q4 Earnings & Revenues; Xtandi Soars - Analyst Blog
2/26/2015 10:20:00 AM - Zacks.com


Integra Lifesciences Tops Q4 Earnings, Revenues; Up Y/Y - Analyst Blog
2/25/2015 9:34:00 AM - Zacks.com


China Biologic Products CBPO) Falls: Stock Goes Down 6% - Tale of the Tape
2/25/2015 8:49:00 AM - Zacks.com


Exact Sciences (EXAS) Falls: Stock Goes Down 5.6% - Tale of the Tape
2/24/2015 9:01:00 AM - Zacks.com


Will Cambrex (CBM) Continue to Surge Higher? - Tale of the Tape
2/19/2015 8:39:53 AM - Zacks.com


Oncolytics' Reolysin Gets Another Orphan Drug Status - Analyst Blog
2/18/2015 4:08:00 PM - Zacks.com


Zacks Rank #1 Additions for Wednesday - Tale of the Tape
2/18/2015 9:30:00 AM - Zacks.com


Increased Earnings Estimates Seen for Cambrex Corporation (CBM): Can It Move Higher? - Tale of the Tape
2/18/2015 8:34:00 AM - Zacks.com


Cambrex (CBM) Worth Watching: Stock Soars 27.5% - Tale of the Tape
2/9/2015 9:25:00 AM - Zacks.com


Cambrex Q4 14 Earnings Conference Call At 8:30 AM ET
2/6/2015 8:30:00 AM - RTT News


Health Care Sector Update for 02/06/2015: TROV, CBM
2/6/2015 8:27:21 AM - MT Newswires


Clean Energy Sells Majority Interest In McCommas Bluff Facility - Quick Facts
1/5/2015 6:29:00 AM - RTT News


Clean Energy Sells Majority Interest In McCommas Bluff Facility - Quick Facts
1/5/2015 6:29:00 AM - RTT News


Cambrex To Present At Oppenheimer Conference; Webcast At 8:00 AM ET
12/11/2014 7:03:00 AM - RTT News


Can the Rally in Cambrex (CBM) Shares Continue? - Tale of the Tape
11/7/2014 8:34:45 AM - Zacks.com


Commit To Buy Cambrex Corp At $15, Earn 11.3% Annualized Using Options
10/16/2014 10:37:20 AM - BNK Invest


Halozyme's PEGPH20 Receives FDA Orphan Drug Designation - Analyst Blog
10/7/2014 4:40:00 PM - Zacks.com


Pluristem Therapeutics, Inc. (PSTI) in Focus: Stock Up 7.4% - Tale of the Tape
10/7/2014 7:44:00 AM - Zacks.com